Novavax (NVAX) Misses Q4 EPS by $1.09
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $9.00 --0%
Revenue Growth %: -78.2%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: -78.2%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q4 EPS of ($2.28), $1.09 worse than the analyst estimate of ($1.19). Revenue for the quarter came in at $357 million versus the consensus estimate of $383.14 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Worthington Industries (WOR) Misses Q4 EPS by 9c
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
